Virax Biolabs Group Ltd. Class A
NASDAQ: VRAX
$1.06
as on
Virax Biolabs Group Ltd. Class A Stock Performance
as on November 4, 2026 at 7:59 am IST
Day's Low
Day's High
$1.04$1.18
1.89%
Downside
11.32%
Upside
52 Week's Low
52 Week's High
$1.10$21.75-3.77%
Downside
1951.89%
Upside
Virax Biolabs Group Ltd. Class A share price movements today
- Previous Close
- $1.10
- Open
- $1.14
- Volume
- 988.7K
- Market Cap
- $1.6M
- Day's Low - High
- $1.04 - $1.18
- 52 Week Low - High
- $1.10 - $21.75
Virax Biolabs Group Ltd. Class A Historical Returns
- 1 Month Return
- -50 %
- 3 Month Return
- -62.59 %
- 1 Year Return
- -91.88 %
- 3 Year Return
- -98.27 %
- 5 Year Return
- 0 %
Virax Biolabs Group Ltd. Class A Stock Fundamentals & Key Indicators
Check Virax Biolabs Group Ltd. Class A market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.6M
EPS (TTM)
-24.89
Dividend Yield
0.00%
PE Ratio (TTM)
-0.05
Industry PE ratio
-3.13
PEG Ratio
-0.00
Return On Equity TTM
-114.24%
Virax Biolabs Group Ltd. Class A vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Virax Biolabs Group Ltd. Class A with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| NA | $1.6M | NA | -0.05 | -1480.46% | 0.00% | |
| Neutral | $88.5B | -36.16% | -27.78 | -12.57% | 0.00% | |
| StrongBuy | $141.7B | 192.56% | 32.27 | 86.04% | 0.00% | |
| Buy | $95.5B | 47.41% | 19.76 | 85.77% | 0.40% |
Stock Returns calculator for Virax Biolabs Group Ltd. Class A Stock including INR - Dollar returns
The Virax Biolabs Group Ltd. Class A stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Virax Biolabs Group Ltd. Class A investment value today
Current value as on today
₹8,353
Returns
Returns from Virax Biolabs Group Ltd. Class A Stock
Dollar Impact
₹530 (+0.53%)
Indian Investors' Interest in Virax Biolabs Group Ltd. Class A Stock
Search interest for Virax Biolabs Group Ltd. Class A Stock has increased by 287% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:287% versus previous 30 day period
Virax Biolabs Group Ltd. Class A Quarterly Profit & Loss
All numbers in Millions USD
Virax Biolabs Group Ltd. Class A Annual Profit & Loss
All numbers in Millions USD
Virax Biolabs Group Ltd. Class A Quarterly Cash Flow
All numbers in Millions USD
Virax Biolabs Group Ltd. Class A Annual Cash Flow
All numbers in Millions USD
Virax Biolabs Group Ltd. Class A News & Key Events
Today's Timeline - 29 October
Thu, 05:18 PM
-Virax Biolabs signs distribution agreements in China for ImmuneSelect products, enhancing sales strategy and market access.
Insights on Virax Biolabs Group Ltd. Class A
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 3 quarters, 1.37K → 12.42K (in $), with an average increase of 50.7% per quarter
NO EFFECTAgainst Peers
In the last 1 year, Moderna, Inc. Common Stock has given 786.5% return, outperforming this stock by 878.4%
- NO EFFECT
Against Peers
In the last 3 years, Moderna, Inc. Common Stock has given 184.8% return, outperforming this stock by 283.1%
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 2 quarters, -2.33M → -5.02M (in $), with an average decrease of 114.8% per quarter
- NEGATIVE IMPACT
Price Dip
In the last 1 month, VRAX stock has moved down by -50.0%
About Virax Biolabs Group Ltd. Class A
| Organisation | Virax Biolabs Group Ltd. Class A |
| Headquarters | BioCity Glasgow, Lanarkshire, SC, ML1 5UH, GB |
| Industry | Biotechnology |
| CEO | James Foster |
Key Management of Virax Biolabs Group Ltd. Class A
Name | Title |
|---|---|
Mr. James Foster | Chairman, CEO & Principal Accounting Officer |
Ms. Lily Fu | Head of Supply Chain |
FAQs
What is Virax Biolabs Group Ltd. Class A share price today?
Virax Biolabs Group Ltd. Class A share price today is $1.06 as on at the close of the market. Virax Biolabs Group Ltd. Class A share today touched a day high of $1.18 and a low of $1.04.
What is the 52 week high and 52 week low for Virax Biolabs Group Ltd. Class A share?
Virax Biolabs Group Ltd. Class A share touched a 52 week high of $21.75 on and a 52 week low of $1.10 on . Virax Biolabs Group Ltd. Class A stock price today i.e. is closed at $1.06,which is 95.13% down from its 52 week high and -3.64% up from its 52 week low.
What is Virax Biolabs Group Ltd. Class A's market capitalisation today?
Virax Biolabs Group Ltd. Class A market capitalisation is $0.00T as on .
How to invest in Virax Biolabs Group Ltd. Class A Stock (VRAX) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Virax Biolabs Group Ltd. Class A on INDmoney app. Click on Buy button.
What is the minimum amount required to buy Virax Biolabs Group Ltd. Class A Stock (VRAX) from India?
Indian investors can start investing in Virax Biolabs Group Ltd. Class A (VRAX) shares with as little as ₹94.73999786376953 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹947.40 in Virax Biolabs Group Ltd. Class A stock (as per the Rupee-Dollar exchange rate as on ).
Based on Virax Biolabs Group Ltd. Class A share’s latest price of $1.06 as on November 4, 2026 at 2:29 am IST, you will get 9.4340 shares of Virax Biolabs Group Ltd. Class A. Learn more about
fractional shares .